Weekly Funding Opportunities

[Med Research]

Guggenheim Fellowship<https://www.gf.org/applicants/apply/>
Established in 1925 by former U.S. senator Simon Guggenheim and his wife in memory of their son, John Simon, who died in 1922 at the age of 17, the foundation has sought from its inception to “add to the educational, literary, artistic, and scientific power of this country, and also to provide for the cause of better international understanding.” To that end, the foundation awards approximately 175 fellowships annually to professionals who have already demonstrated exceptional capacity for productive scholarship or creativity in the arts. Fellowships are awarded for a minimum of six months and a maximum of twelve months, with the goal of providing recipients with blocks of time in which they can work with as much creative freedom as possible. The fellowship is open to writers, scholars, or scientists with a significant record of publication, as well as artists, playwrights, filmmakers, photographers, composers, and others with a significant record of exhibition or performance of their work. Note: Among the 2020 Fellows, there are several in the fields of Biochemistry and Molecular Biology.
Due September 17, 2020. Med-RA deadline to receive draft documents: September 8.

Amyloidosis Foundation Research Grants<http://amyloidosis.org/research/#grant-programs>
The Amyloidosis Foundation is committed to serving patient needs by supporting basic and clinical research and providing annual grants to junior research scientists whose research targets the challenges in the field of amyloidosis. To that end, the foundation welcomes applications from early-career research scientists for its Research Grants program. Through the program, grants of up to $50,000 will be awarded to the recipient's sponsoring institution, in two disbursements, with the second payment contingent on a mid-year update report. Upon request, a second year of funding will be considered, pending review of the research progress and as foundation funding permits. To be eligible, applicants must be within ten years of completion of postdoctoral studies or clinical fellowship and must have a mentor to guarantee that the research environment will support the applicant's research project.
Due September 21, 2020. Med-RA deadline to receive draft documents: September 8.

Greenwall Foundation: Faculty Scholars Program in Bioethics<https://greenwall.org/faculty-scholars-program/scholars-rfp-2020-1>
The Greenwall Faculty Scholars Program in Bioethics is a career development award to enable junior faculty members to carry out innovative bioethics research. It supports research that goes beyond current work in bioethics to help resolve pressing ethical issues in clinical, biomedical, and public health decision-making, policy, and practice, and creates a community that enhances future bioethics research by Scholars and Alumni/ae. Each year, the Foundation selects approximately three Greenwall Faculty Scholars to receive 50 percent salary support for three years to enable them to carry out a specific research proposal and develop their research program.
Letter of intent due September 21, 2020. Med-RA deadline to receive draft documents: September 8.

CASE Fred Morgan Kirby Prize for Scaling Social Impact<https://centers.fuqua.duke.edu/case/practitioners/f-m-kirby-impact-prize/>
The Fred Morgan Kirby Prize for Scaling Social Impact is an annual global prize of $100,000 USD in unrestricted funds that amplifies and accelerates the work of enterprises working to scale their impact on social or environmental problems around the world.  The F. M. Kirby Impact Prize is open to all impact enterprises, working anywhere in the world, that meet the following criteria:

  *   Any nonprofit or for-profit social enterprise working anywhere in the world
  *   Enterprise has strong evidence of impact over at least 3 years and has a plan for how to use the prize to scale that impact in the next 3-5 years
  *   The enterprise has a robust non-discrimination policy that protects against discrimination on the basis of race, religion, national origin, sexual orientation, age, and disability*
  *   Has exemplary leadership that aligns with the core values of Fred Morgan Kirby, including integrity, resourcefulness, resilience, meaningful collaboration and diversity
Due September 30, 2020. Med-RA deadline to receive draft documents: September 17.

NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)<https://grants.nih.gov/grants/guide/pa-files/PAR-20-292.html>
This Funding Opportunity Announcement (FOA) supports preclinical and early phase clinical research, as well as correlative studies, directly related to advancements in cancer treatment, diagnosis, prevention, symptom management, or reduction of cancer health disparities. This includes (but is not limited to) development and testing of the following: new molecular agents or biologics for cancer treatment; management strategies for cancer-related symptoms or treatment-related toxicity; cancer screening or diagnostic tools, such as imaging techniques; cancer preventive agents or approaches; predictive and prognostic biomarkers for patient selection or stratification; clinically relevant in vivo or in vitro tumor models (including genetically engineered mouse models, patient-derived xenograft models, organoids, and cell lines); and strategies to address therapeutic outcome disparities among diverse racial/ethnic populations. In addition to novel agents, new treatment strategies may involve repurposed agents or novel combinations of interventions (including radiation), based on established mechanisms of action. Comparative oncology studies in dogs investigating strategies for treatment and diagnosis of human disease are supported as well. This FOA does not support research that focuses on basic cancer biology (such as studies of cancer-related pathways or molecular mechanisms), late-stage clinical trials, risk assessment studies, epidemiological studies, or studies of behavioral interventions.
Due October 20, 2020; February 19, 2021; June 21, 2021; October 20, 2021; February 22, 2022; and June 21, 2022. Med-RA deadline to receive draft documents for the October 20, 2020 due date: October 7.

NLM Information Resource Grants to Reduce Health Disparities (G08 Clinical Trial Not Allowed)<https://grants.nih.gov/grants/guide/pa-files/PAR-20-283.html>
This Funding Opportunity Announcement solicits resource grant applications for projects that will bring useful, usable health information to health disparity populations and their health care providers. Access to useful, usable, understandable health information is an important factor when making health decisions. Proposed projects should exploit the capabilities of computer and information technology and health sciences libraries to bring health-related information to consumers and their health care providers.
Due October 23, 2020; October 22, 2021; and October 21, 2022. Med-RA deadline to receive draft documents for the October 23, 2020 due date: October 12.

Visualization Methods and Tools Development for Enhancing Cancer Moonshot Data (R33 Clinical Trial Not Allowed)<https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-044.html>
Through this Funding Opportunity Announcement (FOA), the National Cancer Institute  as a part of its Beau Biden Cancer Moonshot Initiative invites submission of applications requesting support for projects that will accelerate cancer research. Specifically, this FOA falls under a scientific priority designated by the Blue Ribbon Panel as Recommendation J, the development of New Enabling Cancer Technologies<https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/new-technologies>. The purpose of this FOA is to stimulate the development of new cancer data visualization methods and tools that have the potential to make data aligned with the Cancer Moonshot more explorable and interpretable by the broader cancer research community. This FOA supports the development of new, full-featured data visualization tools for investigator-specified, Moonshot-aligned use cases that enable a broader community of users to explore and gain insights from data emerging from or aligned with one or more of the Cancer Moonshot areas.
Due October 30, 2020. Med-RA deadline to receive draft documents: October 19.

NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)<https://grants.nih.gov/grants/guide/pa-files/PAR-20-259.html>
The NIAID New Innovator Award supports a postdoctoral or newly independent Early Stage Investigator<https://grants.nih.gov/policy/early-investigators/index.htm> of exceptional creativity who proposes novel, original and insightful research concepts with the potential to produce a major impact, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research of priority to NIAID. Applications proposing unexpected convergence of disciplines, new scientific directions, or the use of novel methodologies are encouraged. Applications from individuals with diverse backgrounds and in any topic relevant to the mission of NIAID<https://www.niaid.nih.gov/research/role> are welcome.
Due November 2, 2020; October 14, 2021; and October 14, 2022. Med-RA deadline to receive draft documents for November 2, 2020 due date: October 20.

NSF Biology Integration Institutes<https://www.nsf.gov/pubs/2020/nsf20601/nsf20601.htm>
Biology has transformed science over the last century through discoveries that cross subdisciplines from the molecular to the organismal to the ecosystem level. While making great progress, biology has also slowly fragmented into subdisciplines, creating a dynamic tension between unifying principles and increasingly reductionist pursuits. The aim of this solicitation is to bring researchers together around the common goal of understanding how the processes that sustain life and enable biological innovation operate and interact within and across different scales of organization, from molecules to cells, tissues to organisms, species, ecosystems, biomes and the entire Earth. The Biology Integration Institutes program supports collaborative teams of researchers investigating questions that span multiple disciplines within and beyond biology. Integration across biological disciplines is essential if we hope to understand the diverse and ever-increasing data streams of modern biology and tackle emergent questions about living organisms and the environment. Of equal importance is the need for groundbreaking and sustainable training programs that prepare the next generations of scientists to navigate the breadth of biological sciences, training in multiple disciplines without sacrificing depth of learning or innovation. In addition, the biology community must continue to develop practices and adopt strategies that leverage rapid advances in cyberinfrastructure and other technologies to bridge and integrate across subdisciplines and make resources accessible, re-usable, and adaptable for unanticipated purposes. In these ways, Biology Integration Institutes will focus on biological themes that enable the discoveries of life’s innovations. The outcomes from biological integration will inspire new biotechnologies and applications to drive our bioeconomy and provide solutions to societal challenges. While this solicitation focuses on the integration of biological subdisciplines, any field beyond biology may be included as needed to address the overarching biological theme.
Due January 13, 2021. Med-RA deadline to receive draft documents: January 4.

Disseminating and Implementing Patient-Centered Outcomes Research (PCOR) Evidence into Practice through Interoperable Clinical Decision Support (R18)<https://grants.nih.gov/grants/guide/pa-files/PA-20-074.html>
This Funding Opportunity Announcement invites R18 grant applications that disseminate and implement patient-centered outcomes research evidence in clinical practice by scaling computer-based, interoperable clinical decision support.
Standard dates apply. Expires January 26, 2022. Med-RA deadline to receive draft documents for January 25, 2021 standard date: January 11.

RESolution of InflammaTion in EnvirOnmentally Related diseasE (RESTORE) (R01 Clinical Trial Not Allowed)<https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-20-013.html>
The purpose of the RESTORE program is to advance understanding of the role of inflammation resolution pathways at the cellular and molecular level and how exposure to environmental pollutants interferes with these pathways resulting in exposure-induced chronic systemic inflammation and ultimately chronic disease conditions. The initial phase of this program is focused on understanding how chronic exposure to air pollution interferes with resolution of inflammation in pulmonary, cardiovascular, and metabolic systems and diseases.
Due February 11, 2021. Med-RA deadline to receive draft documents: February 1.

Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)<https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-022.html>
The purpose of this Funding Opportunity Announcement is to support multidisciplinary research teams with complementary expertise in HIV and pathobiology, pathophysiology, and/or metabolism in organs, tissues, and/or biological systems of specific interest to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). These teams will comprehensively interrogate fundamental mechanisms underlying HIV-associated comorbidities, coinfections, and complications relevant to the mission of the NIDDK and advance progress toward alleviating them.
Due March 3, 2021 and November 17, 2021. Med-RA deadline to receive draft documents for the March 3, 2021 due date: February 18.

NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional)<https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-21-023.html>
This Funding Opportunity Announcement (FOA) invites submission of Program Project (P01) applications to support integrated, multi-project research programs that address HIV scientific areas relevant to the NICHD mission as a well-defined, central research focus or objective.
Due March 31, 2021. Med-RA deadline to receive draft documents: March 18.

Forecasts
Addressing Racial and Ethnic Disparities to Improve Health Outcomes<https://www.grants.gov/web/grants/view-opportunity.html?oppId=328672>
The HHS Office of Minority Health is offering funding to support State and local collaborative teams in implementing a methodological framework and strategies for assessing and addressing structural racism in health policies, developed through a complementary policy academy initiative. In particular, awardees will: (1) Obtain governmental and public buy-in for engaging in this policy collaborative endeavor; (2) Create a multi-sector team (e.g., comprised of leadership from the governor's/mayor's office and health, behavioral health, child welfare, justice, education, commerce, community service and other agencies, and from community organizations); (3) Conduct a review of existing policies to identify the areas primed for a structural racism assessment; (4) Develop or revise a policy (or policies) to address structural racism and improve health outcomes; (5) Implement the new/revised policy and evaluate its impact on health outcomes for racial and ethnic minorities within their jurisdiction; and (6) Create and implement strategies to communicate, sustain and spread policies resulting in improved health outcomes for racial and ethnic minorities. BACKGROUND: Racial and ethnic minority populations experience a number of disparities which contribute to poor health outcomes. Structural racism, evidenced in residential segregation, inequitable allocation and quality of services and resources such as health care and education, disproportionate contact with the justice system, and lack of access to employment opportunities, plays a persistent and large role in historical disadvantage and supports the persistence of racial and ethnic health disparities.
Estimated post date: December 31, 2020
Estimated due date: March 31, 2021

To search for additional funding opportunities, please visit CoM’s unofficial funding opportunities blog<https://urldefense.proofpoint.com/v2/url?u=https-3A__fsucomgrants.wordpress.com_&d=DwMGaQ&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=-WQkPIXZLCgXlX-d14DY8B-SG-GvP9FZHr_Gv8sUuTQ&s=ErAzzubGxiJsWCKGnlFjfXV6980C-DCl-AxzFLHMVYQ&e=>.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.fsu.edu/pipermail/com_funding_opportunities/attachments/20200828/5ea66344/attachment.html>